Medical device company Penumbra (NYSE:PEN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up ...

Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know.

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including ...

On a per-share basis, the Alameda, California-based company said it had net income of 86 cents. Earnings, adjusted for non-recurring costs, came to 97 cents per share. The results beat Wall Street ...

Penumbra, Inc. (NYSE:PEN – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The company traded as high as $304.

Penumbra (PEN) came out with quarterly earnings ... A quarter ago, it was expected that this medical device maker would post earnings of $0.69 per share when it actually produced earnings of ...

Penumbra (NYSE:PEN – Free Report) had its price objective increased by Robert W. Baird from $305.00 to $328.00 in a report ...